Quality of Life Research

, Volume 14, Issue 4, pp 981–990

The relationship between lipodystrophy-associated body changes and measures of quality of life and mental health for HIV-positive adults

  • Robert Burgoyne
  • Evan Collins
  • Cheryl Wagner
  • Susan Abbey
  • Mark Halman
  • Margaret Nur
  • Sharon Walmsley
Article

Abstract

Objectives:To investigate the relationship between lipodystrophy-specific symptom severity and wellbeing. Methods:HIV-positive adult patients with body fat redistribution (lipodystrophy syndrome) associated with antiretroviral therapy reported their total non-lipodystrophy symptoms and side effects and completed measures assessing body fat changes (yielding Atrophy, Hypertrophy and Total Lipodystrophy scores), mental health and quality of life. Effects of total symptom complex and lipodystrophy severity on quality of life and mental health were analyzed using Spearman’s rho correlations. Logistic regression analyses were utilized to determine the relative-odds of depression produced by overall symptom count and lipodystrophy score increments. Results:Mean ratings for Hypertrophy and Atrophy corresponded to ‘very mild’ and ‘mild’ degrees of severity, respectively. The total symptom complex was associated with ratings for most of the mental health and quality of life measures. Patient-perceived body image scores were the sole study variable responsive to lipodystrophy severity ratings. In comparison to reference norms, a pronounced degree of body image impairment was evident. Conclusion: Although responsive to the total symptom profile, psychosocial measures typically utilized for evaluating quality of life and mental health status in HIV disease lacked sensitivity and specificity for measuring the consequences of lipodystrophy-associated fat distribution changes alone. Lipodystrophy severity did impact negatively on body image.

Keywords

Body image HIV Lipodystrophy Mental health Quality of life 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Badia, X, Podzamczer, D, Garcia, M, Lopez-David, C, Consiglio, E. 1999A randomized study comparing instruments for measuring health-related quality of life in HIV-infected patientsAIDS1317271735PubMedGoogle Scholar
  2. 2.
    Burgoyne, R, Renwick, R. 2004Social support and quality of life over time among adults living with HIV in the HAART eraSoc Sci Med5813531366PubMedGoogle Scholar
  3. 3.
    Burgoyne, R, Saunders, D. 2001Quality of life among urban Canadian HIV/AIDS clinic outpatientsInt J STD AIDS12505512PubMedGoogle Scholar
  4. 4.
    Carrieri, P, Spire, B, Duran, S, Katlama, C, Peyramond, D, Francois, C,  et al. 2003Health-related quality of life after 1 year of highly active antiretroviral therapyJ Acquir Immune Defic Syndr323847PubMedGoogle Scholar
  5. 5.
    Cunningham, W, Shapiro, M, Hays, R, Dixon, W, Visscher, B, George, L,  et al. 1998Constitutional symptoms and health-related’quality of life in patients with symptomatic HIV diseaseAm J Med104129136PubMedGoogle Scholar
  6. 6.
    Murri, R, Ammassari, A, Fantoni, M, Scoppettuolo, G. 1997Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV health surveyJ AIDS Hum Retrovirol16350356Google Scholar
  7. 7.
    Saunders, D, Burgoyne, R. 2002Evaluating health-related wellbeing outcomes among outpatient adults with human immunodeficiency virus infection in the HAART eraInt J STD AIDS13683690PubMedGoogle Scholar
  8. 8.
    Vogl, D, Rosenfeld, B, Breitbart, W, Thaler, H, Passik, S, McDonald, M,  et al. 1999Symptom prevalence, characteristics, and distress in AIDS outpatientsJ Pain Symptom Manage18253262PubMedGoogle Scholar
  9. 9.
    Wachtel, T, Piette, J, Mor, V, Stein, M, Fleishman, J, Carpenter, C. 1992Quality of life in persons with human immunodeficiency virus infection: Measurement by the medical outcomes study instrumentAnn Intern Med116129137PubMedGoogle Scholar
  10. 10.
    Wu, A, Rubin, H, Mathews, W, Ware, J, Brysk, L, Hardy, W,  et al. 1991A health status questionnaire using 30 items from the medical outcomes studyMed Care29786798PubMedGoogle Scholar
  11. 11.
    Carr, A, Samaras, K, Thorisdottir, A, Kaufmann, G, Chisholm, D, Cooper, D. 1999Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia and diabetes mellitus: A cohort studyLancet35320932099PubMedGoogle Scholar
  12. 12.
    Heath, K, Hogg, R, Chan, K, Harris, M, Montessori, V, O’Shaugnessy, M,  et al. 2001Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment databaseAIDS15231239PubMedGoogle Scholar
  13. 13.
    Schambelan, M, Benson, C, Carr, A, Currier, J, Dube, M, Gerber, J,  et al. 2002Management of metabolic complications associated with antiretroviral therapy for HIV-1 infection: Recommendations of an International AIDS Society-USA panelJ AIDS31257275Google Scholar
  14. 14.
    Hogg, R, Heath, K, Yip, B, Craib, K, O’Shaughnessy, M, Schecter, M,  et al. 1998Improved survival among HIV-infected individuals following initiation of antiviral therapyJAMA279450454PubMedGoogle Scholar
  15. 15.
    Palella, F, Delaney, K, Moorman, A, Loveless, M, Fuhrer, J, Satten, G,  et al. 1998Declining morbidity and mortality among patients with advanced human immunodeficiency virus infectionN Engl J Med338853860CrossRefPubMedGoogle Scholar
  16. 16.
    Bassetti, S, Battegay, M, Furrer, H, Rickenback, M, Flepp, M, Kaiser, L 1999Why is highly active antiretroviral therapy (HAART) not prescribed or discontinued?J AIDS21114119Google Scholar
  17. 17.
    Shafer, R, Vuitton, D. 1999Highly active antiretroviral therapy (HAART) for the treatment of infection with human immunodeficiency virus type 1Biomed Pharmacother537386PubMedGoogle Scholar
  18. 18.
    Collins, E, Wagner, C, Walmsley, S. 2000Psychosocial impact of the lipodystrophy syndrome in HIV infectionAIDS Reader10546550PubMedGoogle Scholar
  19. 19.
    Dukers, H, Stolte, I, Albrecht, N, Coultinho, R, Wit, J 2001The impact of experiencing lipodystrophy on the sexual behaviour and well-being among HIV-infected homosexual men [Letter]AIDS15812813PubMedGoogle Scholar
  20. 20.
    Oette, M, Juretzko, P, Kroidl, A, Sagir, A, Wettstein, M, Siegrist, J,  et al. 2002Lipodystrophy syndrome and self-assessment of well-being and physical appearance in HIV-positive patientsAIDS Patient Care16413417Google Scholar
  21. 21.
    Paton, N, Earnest, A, Ng, Y, Karim, F, Aboulhab, J. 2002Lipodystrophy in a cohort of human immunodeficiency virus-infected Asian patients: Prevalence, associated factors and psychological impactClin Infect Dis3512441249PubMedGoogle Scholar
  22. 22.
    Power, R, Tate, H, McGill, S, Taylor, C. 2003A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individualsSex Transm Infect79137141PubMedGoogle Scholar
  23. 23.
    Lenert, L, Feddersen, M, Sturley, A, Lee, D. 2002Adverse effects of medications and trade-offs between length of life and quality of life in human immunodeficiency virus infectionAm J Med113229232PubMedGoogle Scholar
  24. 24.
    Blanch, J, Rousaud, A, Martinez, E, De Lazzari, E, Peri, J, Milinkovic, A,  et al. 2002Impact of lipodystrophy on the quality of life of HIV-1-infected patientsJ Acquir Immune Defic Syndr31404407PubMedGoogle Scholar
  25. 25.
    Carr, A, Samaras, K, Burton, S, Freund, J, Chisholm, D, Cooper, D. 1998A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitorsAIDS12F51F58PubMedGoogle Scholar
  26. 26.
    Justice, A, Rabeneck, L, Hays, R, Wu, A, Bozzette, S. 1999Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptomsJ AIDS21126133Google Scholar
  27. 27.
    Wu, A, Revicki, D, Jacobson, D, Malitz, F. 1997Evidence for reliability, validity and usefulness of the Medical Outcome Study HIV Health Survey (MOS-HIV)Qual Life Res6481493PubMedGoogle Scholar
  28. 28.
    Holmes, W, Shea, J. 1998A new HIV/AIDS-targeted quality of life (HAT-QOL) instrument: Development, reliability and validityMed Care36138154PubMedGoogle Scholar
  29. 29.
    Ganz, P, Schag, C, Kahn, B, Petersen, L, Hirji, K. 1993Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems–Evaluation System (HOPES)Qual Life Res2109119PubMedGoogle Scholar
  30. 30.
    Martinez, E, Garcia-Viejo, M, Blanch, J, Gatell, J 2001Lipodystrophy syndrome in patients with HIV infection: Quality of life issuesDrug Safety24157166PubMedGoogle Scholar
  31. 31.
    Derogatis, L, Melisaratos, N. 1979The DSFI: A multidimensional measure of sexual functioningJ Sex Marital Ther5244281PubMedGoogle Scholar
  32. 32.
    Spielberger, C, Gorsuch, R, Lushene, R, Vagg, P, Jacobs, G. 1983State-Trait Anxiety Inventory for AdultsMind Garden Inc.Palo Alto CAGoogle Scholar
  33. 33.
    Rosenberg, M. 1965Society and the Adolescent Self-ImagePrinceton University PressPrinceton NJGoogle Scholar
  34. 34.
    Beck A, Steer R, Brown G. BDI -II Manual for Beck Depression Inventory, 2nd edition, San Antonio, TX: The Psychological Corporation (Harcourt Brace & Co.), 1996.Google Scholar
  35. 35.
    Chapman, L. 1998Body image and HIV: Implications for support and careAIDS Care.10S179S189PubMedGoogle Scholar
  36. 36.
    Burgoyne, R, Rourke, S, Behrens, D, Salit, I. 2004Long-term quality of life outcomes among adults living with HIV in the HAART era: The interplay of changes in clinical factors and symptom profileAIDS Behav8151163PubMedGoogle Scholar
  37. 37.
    Fontaine, A, Larue, F, Lassauniere, J. 1999Physicians’ recognition of the symptoms experienced by HIV patients: How reliable?J Pain Symptom Manage18263270PubMedGoogle Scholar
  38. 38.
    Justice, A, Chang, C, Rabeneck, L, Zackin, R. 2001Clinical importance of provider-reported HIV symptoms compared with patient-reportMed Care39397408PubMedGoogle Scholar

Copyright information

© Springer 2005

Authors and Affiliations

  • Robert Burgoyne
    • 1
    • 2
    • 6
  • Evan Collins
    • 1
    • 2
  • Cheryl Wagner
    • 3
  • Susan Abbey
    • 1
    • 2
  • Mark Halman
    • 2
    • 4
  • Margaret Nur
    • 1
  • Sharon Walmsley
    • 1
    • 5
  1. 1.Toronto General HospitalCanada
  2. 2.Department of PsychiatryUniversity of TorontoCanada
  3. 3.HIV primary care physicianCanada
  4. 4.St. Michael’s HospitalCanada
  5. 5.Department of MedicineUniversity of TorontoTorontoCanada
  6. 6.Toronto General Hospital Immunodeficiency ClinicTorontoCanada

Personalised recommendations